Karen Anderson, APRN
NPI 1154943397 · Family Nurse Practitioner · Westlake, LA
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1154943397
- Entity type
- Individual
- Primary specialty
- Family Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- APRN
- Sex
- Female
- Sole proprietor
- Yes
- License
- RN128195 (LA)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
6 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
488 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 137 | $100 |
| Detection Test By Immunoassay With Direct Visual Observation for Influenza Virus87804 | 120 | $16 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 47 | $11 |
| Detection Test By Immunoassay With Direct Visual Observation for Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19)87811 | 46 | $40 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 43 | $132 |
| Detection Test By Immunoassay With Direct Visual Observation for Streptococcus, Group a (strep)87880 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Amoxicillin/Potassium Clavbrand: Amoxicillin-Clavulanate Potass | 21 | 21 |
| Prednisone | 17 | 16 |
| Amoxicillin | 14 | 13 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 13 | 13 |
| Azithromycin | 13 | 13 |
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro | 13 | 12 |
| Sulfamethoxazole/Trimethoprim |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$61 across 3 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2020-05-11
- Last updated
- 2023-07-11
- Certified
- 2023-07-03
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.